SCHEMBL7988641

SCHEMBL7988641

CCC(=O)Nc1ncn(Cc2ccc(-c3ccccc3)cc2)c1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
FGFR1 P11362 1/20 0.43
FGFR4 P22455 1/20 0.43
PKM P14618 2/20 0.42
GAA P10253 1/20 0.42
TSHR P16473 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
IKBKB O14920 1/20 0.40
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991565 0.93 TSHR (0.49) KMT2AFGFR1FGFR4PKMGAA
SCHEMBL7973987 0.87 FGFR1 (0.45) KMT2AFGFR1FGFR4PKMGAA
SCHEMBL7974223 0.86 RAB9A (0.46) GAANPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7984273 0.85 PPARG (0.40) FGFR1FGFR4GSK3AGSK3BADORA2A
SCHEMBL7987598 0.84 RIOK2 (0.41) KMT2AMEN1FGFR1FGFR4RAB9A
SCHEMBL7984711 0.84 ABCC8 (0.44) FGFR1FGFR4NPC1RAB9AKDM4E
SCHEMBL7987555 0.84 GAA (0.47) KMT2AMEN1PKMGAATSHR
SCHEMBL7986400 0.83 YTHDC1 (0.47) KMT2AMEN1FGFR1FGFR4GAA
SCHEMBL7987930 0.82 KMT2A (0.57) KMT2AMEN1NPC1RAB9ALMNA
SCHEMBL7974162 0.82 KDM4E (0.52) KMT2AFGFR1FGFR4SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed